 Connection
Christopher Nitkin to Infant, Newborn
This is a "connection" page, showing publications Christopher Nitkin has written about Infant, Newborn.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.584 |
|
|
|
-
Nitkin CR, Richardson T, Lewis T. Is Anti-Vascular Growth Factor Therapy for Retinopathy of Prematurity Associated With Pulmonary Hypertension?-Reply. JAMA Ophthalmol. 2023 04 01; 141(4):408-409.
Score: 0.181
-
Nitkin CR, Bamat NA, Lagatta J, DeMauro SB, Lee HC, Patel RM, King B, Slaughter JL, Campbell JP, Richardson T, Lewis T. Pulmonary Hypertension in Preterm Infants Treated With Laser vs Anti-Vascular Endothelial Growth Factor Therapy for Retinopathy of Prematurity. JAMA Ophthalmol. 2022 11 01; 140(11):1085-1094.
Score: 0.176
-
Nitkin CR, Rajasingh J, Pisano C, Besner GE, Th?baud B, Sampath V. Stem cell therapy for preventing neonatal diseases in the 21st century: Current understanding and challenges. Pediatr Res. 2020 01; 87(2):265-276.
Score: 0.139
-
Santharam Y, Nitkin CR, Rajgarhia A, Oschman A, Lee B, Fischer R, Feldman K. Association between congenital heart disease and parenteral nutrition-associated liver disease in neonates: A retrospective cohort study. JPEN J Parenter Enteral Nutr. 2023 05; 47(4):501-510.
Score: 0.045
-
Feldman K, Nitkin CR, Cuna A, Oschman A, Truog WE, Norberg M, Nyp M, Taylor JB, Lewis T. Corticosteroid response predicts bronchopulmonary dysplasia status at 36 weeks in preterm infants treated with dexamethasone: A pilot study. Pediatr Pulmonol. 2022 07; 57(7):1760-1769.
Score: 0.043
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|